Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.
Press releases published on October 22, 2025
PreludeSys and its Sub-Brands Evolve into LevelShift to Drive Industry-Specific AI Transformation
CHENNAI, TAMIL NADU, INDIA, October 22, 2025 /EINPresswire.com/ -- PreludeSys, along with its sub-brands DemandBlue and DemandDynamics, today announced its evolution into LevelShift, a new unified brand dedicated to helping organizations transform into …
ChiCha Secures Vibranium Audit, Engages Binance-Tier Security Partner Ahead of $CHI Launch
AI-powered stablecoin wallet ChiCha partners with a top-tier Web3 security firm, reinforcing trust and readiness ahead of the $CHI token launch. SINGAPORE, SINGAPORE, October 22, 2025 /EINPresswire.com/ -- ChiCha, the AI-powered stablecoin wallet …
Digital Align’s CUSO Secures Investment from Community First Credit Union of Florida, Expanding Momentum for AI Agents
A leader in discovery and intelligent automation, providing specialized Digital Agents that enable scalable transformation for community financial institutions. FREMONT, CA, UNITED STATES, October 22, 2025 /EINPresswire.com/ -- Digital Align Inc., a …
Marfin and Complexio Accelerate Enterprise Automation Across Core Business Operations
Partnership demonstrates how AI can understand and automate complex workflows across enterprise functions. MONACO, October 22, 2025 /EINPresswire.com/ -- Marfin today announced the successful completion of its first automation discovery and …
AGII Adds Real-Time Learning Intelligence to Improve Blockchain Reliability
The enhancement introduces adaptive capabilities to ensure greater consistency, resilience, and performance across decentralized systems. SINGAPORE, SINGAPORE , SINGAPORE, October 22, 2025 /EINPresswire.com/ -- AGII, a next-generation AI platform …
Colle AI Deploys Automation Tools to Streamline NFT Publishing and Collaboration
New AI-driven systems accelerate NFT releases, enhance teamwork, and simplify cross-chain deployment workflows SINGAPORE, SINGAPORE , SINGAPORE, October 22, 2025 /EINPresswire.com/ -- Colle AI (COLLE), the multichain AI-powered NFT platform, has …
MEDDIC Academy Launches the Official MEDDPICC® App, A GPS for Winning B2B Deals
The new MEDDPICC® App transforms how sellers assess, qualify and advance opportunities by inspecting, scoring and taking action on them. NEWPORT BEACH, CA, UNITED STATES, October 22, 2025 /EINPresswire.com/ -- MEDDIC Academy, a global provider of sales …
Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium
Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and P53 Y220C reactivator Candidates for FGFR3 and SMARCA2 programs identified: IND enabling studies anticipated in …
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed by Elevara from Japan’s Teijin Pharma with good tolerability and safety, plus early signs of efficacy in …
GBI selects Nokia to build new network for faster, more resilient connectivity across the Middle East
Press Release GBI selects Nokia to build new network for faster, more resilient connectivity across the Middle East GBI’s new network with Nokia will enhance its regional optical infrastructure with state-of-the-art technology that supports faster, more …
A2MAC1 and ZeBeyond partner to bring Simulation-First Powertrain Benchmarking to market
Munich, 22.10.2025 – A2MAC1 and ZeBeyond announce a strategic collaboration that introduces a simulation-first benchmarking platform for electric powertrains. The new approach enables OEMs and Tier 1 suppliers to validate vehicle efficiency and performance …
Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study Efdoralprin alfa demonstrated superiority in a head-to-head study versus a standard of care plasma-derived therapy Results …
Communiqué de presse : L’efdoralprine alfa de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase II sur l’emphysème par déficit en alpha-1-antitrypsine
L’efdoralprine alfa de Sanofi a atteint tous les critères d’évaluation principaux et secondaires clés dans l’étude de phase II sur l’emphysème par déficit en alpha-1-antitrypsine L’efdoralprine alfa a démontré sa supériorité dans une une étude comparative …
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology, strengthening its pipeline
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a new standard of care in combination in first line unfit …
Ipsen annonce son intention d’acquérir ImCheck Therapeutics et étend son leadership en oncologie avec un portefeuille enrichi de produits en R&D
Acquisition axée sur le programme clinique phare ICT01 dans le domaine de la leucémie myéloïde aiguë, dont les données issues de l'essai EVICTION de phase I/II en cours ont montré une réponse thérapeutique élevée. ICT01 pourrait devenir une nouvelle norme …
BAWAG Group erzielte in Q3 2025 Nettogewinn von 219 Mio. € und RoTCE von 27,8%; 2025-Ziele werden voraussichtlich übertroffen
WIEN, 22. Oktober 2025 – BAWAG Group gibt heute ihre Ergebnisse für das dritte Quartal 2025 bekannt. Die Geschäftsentwicklung der BAWAG Group blieb weiterhin stark, mit einem Nettogewinn in Höhe von 219 Mio. €, einem Gewinn je Aktie von 2,77 €, und einem …
BAWAG Group publishes Q3 2025 results: Net profit €219 million and RoTCE 27.8%; on track to exceed 2025 targets
VIENNA, Austria – October 22, 2025 – Today, BAWAG Group released its results for the third quarter 2025. The operating performance of our business remained strong with a net profit of €219 million, earnings per share of €2.77, and a RoTCE of 27.8%. Pre- …